Betasight Technologies

Betasight Technologies

A company developing software to be used with virtual reality (VR) headsets with eye-tracking to test eye diseases such as glaucoma and monitor neurological health.

All edits

Edits on 13 August, 2019
Golden AI"IBI-79"
Golden AI edited on 13 August, 2019 7:48 pm
Edits made to:
Infobox (+3 properties)
Infobox
Company legal name
Betasight Pte Ltd
Founded date
January 22, 2018
Edits on 14 April, 2019
Jessica Karpinski
Jessica Karpinski edited on 14 April, 2019 8:22 pm
Edits made to:
Infobox (+2 properties)
Infobox
Edits on 11 April, 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 11 April, 2019 6:48 pm
Edits made to:
Infobox (+1 properties)
Infobox
Meredith Hanel
Meredith Hanel edited on 11 April, 2019 1:36 pm
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 29 March, 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 29 March, 2019 6:17 pm
Edits made to:
Article (+18/-18 characters)
Article

BetaSight's founders Martin Sawtell and Corey Manders met in 2017, at Entrepreneur FirstEntrepreneur First in Singapore. They had computer vision and visual effects backgrounds and personal experiences with eye movement and vertigo and the development of software for ophthalmic devices.

Edits on 28 March, 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 28 March, 2019 1:36 pm
Edits made to:
Article (+9/-9 characters)
Article

BetaSight's founders Martin Sawtell and Corey Manders met in 2017, at Entrepreneur First in SingaporeSingapore. They had computer vision and visual effects backgrounds and personal experiences with eye movement and vertigo and the development of software for ophthalmic devices.

Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 28 March, 2019 1:33 pm
Edits made to:
Article (+11/-11 characters)
Article

Betasight is developing a new use for VR, in ophthalmology, where VR headsets with eye-tracking are used to perform functional testing of eye health. Since the head mounted displays can generate everything a person can see the company is learning how they respond via eye-tracking. Glaucoma is the first target eye diseaseeye disease they are using their technology to test for. If detected early, treatments can slow disease progression.

Meredith Hanel
Meredith Hanel edited on 28 March, 2019 1:03 pm
Edits made to:
Infobox (+7 properties)
Description (+164 characters)
Article (+1443 characters)
People (+2 rows) (+4 cells) (+70 characters)
Categories (+1 topics)
Topic thumbnail

Betasight Technologies

A company developing software to be used with virtual reality (VR) headsets with eye-tracking to test eye diseases such as glaucoma and monitor neurological health.

Article

Betasight is developing a new use for VR, in ophthalmology, where VR headsets with eye-tracking are used to perform functional testing of eye health. Since the head mounted displays can generate everything a person can see the company is learning how they respond via eye-tracking. Glaucoma is the first target eye disease they are using their technology to test for. If detected early, treatments can slow disease progression.

BetaSight's founders Martin Sawtell and Corey Manders met in 2017, at Entrepreneur First in Singapore. They had computer vision and visual effects backgrounds and personal experiences with eye movement and vertigo and the development of software for ophthalmic devices.

The company uses off the shelf VR hardware along with established authoring tools and works with clinical partners to rapidly prototype and test diagnostic methodologies. Betasight is using machine learning techniques to optimize testing and find new diagnostic opportunities.

To take BetaSight's test, patients wear a headset and follow points of light with their eyes. Data collected is also used to train neural networks with the goal of enabling the system to make predictions based on eye movements, such as probability that the person has glaucoma, age-related macular degenertion, diabetic retinopathy or other diseases. Clinical trials are planned to evaluate the eye-tracking-based glaucoma test compared with existing diagnostic methods.

People

Name
Role
Related Golden topics

Dr. Corey Manders

Co-founder, Director

Mr. Martin Sawtell

Co-founder, CEO

Infobox
Categories
Meredith Hanel"Initial topic creation"
Meredith Hanel created this topic on 28 March, 2019 12:26 pm
Edits made to:
Topic thumbnail

 Betasight Technologies

A company developing software to be used with virtual reality (VR) headsets with eye-tracking to test eye diseases such as glaucoma and monitor neurological health.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.